{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Antioxidant Therapy in the Perinatal Period"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised using a computer-generated sequence, with allocation concealment ensured through sealed envelopes"
      },
      "Participants": {
        "score": 2,
        "evidence": "pregnant women aged 18-40 years with gestational ages between 20-28 weeks, at risk of oxidative stress-related complications"
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received antioxidant therapy, while the control group received a placebo"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the impact of antioxidant therapy on reducing oxidative stress-related complications during the perinatal period"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of preterm birth, assessed until delivery"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "randomised using a computer-generated sequence, with allocation concealment ensured through sealed envelopes"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was applied to outcome assessors, patients, and clinicians"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, between January 2020 and June 2021"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted using an intention-to-treat approach, with 98 participants in the intervention group and 97 in the control group"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group demonstrated a significant reduction in preterm birth rates compared to the control group (mean difference = 10%, 95% CI 5% to 15%; p = 0.01)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, occurring in 3% of the intervention group and 1% of the control group"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health"
      }
    },
    "total_score": 25,
    "max_score": 25
  },
  "model": "gpt-4o"
}